PT  - JOURNAL ARTICLE
AU  - Charles Brink
AU  - Sven-Erik Dahlén
AU  - Jeffrey Drazen
AU  - Jilly F. Evans
AU  - Douglas W. P. Hay
AU  - G. Enrico Rovati
AU  - Charles N. Serhan
AU  - Takao Shimizu
AU  - Takehiko Yokomizo
TI  - International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
AID  - 10.1124/pr.56.1.4
DP  - 2004 Mar 01
TA  - Pharmacological Reviews
PG  - 149--157
VI  - 56
IP  - 1
4099  - http://pharmrev.aspetjournals.org/content/56/1/149.short
4100  - http://pharmrev.aspetjournals.org/content/56/1/149.full
SO  - Pharmacol Rev2004 Mar 01; 56
AB  - Oxoeicosanoids are a family of biologically active arachidonic acid derivatives that have been intimately linked with cellular migration. These metabolites are not only potent chemotaxins but also elicit oxygen radical production as well as induce secretory events in different cells. The most potent native ligand reported is 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE), and the cell membrane receptor activated has now been cloned. This receptor is distinct from those receptors activated by either the prostaglandins or the leukotrienes. The purpose of this review is to briefly summarize the molecular evidence and highlight the significance of this receptor. In addition, an official nomenclature for this oxoeicosanoid receptor is proposed.